• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于诊断脑卒中后认知障碍的蒙特利尔认知评估的截断值是多少?一项关于诊断准确性的系统评价和荟萃分析。

Which cutoff value of the Montreal Cognitive Assessment should be used for post-stroke cognitive impairment? A systematic review and meta-analysis on diagnostic test accuracy.

机构信息

Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, China.

Nursing Department, Gansu Provincial Hospital, Lanzhou, China.

出版信息

Int J Stroke. 2023 Oct;18(8):908-916. doi: 10.1177/17474930231178660.

DOI:10.1177/17474930231178660
PMID:37190789
Abstract

BACKGROUND

Post-stroke cognitive impairment (PSCI) is one of the serious complications of stroke. The Montreal Cognitive Assessment (MoCA), as a brief cognitive impairment screening tool, is widely used in stroke survivors. However, some studies have suggested that the use of the universal cutoff value of 26 may be inappropriate for detecting cognitive impairments in stroke settings.

AIM

We conducted this study to identify the optimal cutoff value of the MoCA in screening for PSCI.

METHODS

PubMed, CINAHL, Embase, the Cochrane Library, and Web of Science were searched for eligible studies until March 23, 2023. All studies were screened by two independent researchers. The quality of each article was evaluated by the Quality Assessment of Diagnostic Accuracy Studies-2 tool. A bivariate mixed-effects model was used to pool sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and the summary receiver operating characteristic curve.

RESULTS

Twenty-four studies with a total of 4231 patients were included in this review. Despite the lack of evidence of publication bias, a high degree of heterogeneity was observed. A meta-analysis revealed that a cutoff value of 21/22 yielded the best diagnostic accuracy. The optimal cutoff varied in different regions, stroke types, and stroke phases as well.

CONCLUSION

The optimal cutoff of MoCA was 21/22 for stroke populations rather than the initially recommended cutoff of 26. A revised (lower) cutoff should be considered for stroke survivors.

摘要

背景

脑卒中后认知障碍(PSCI)是脑卒中的严重并发症之一。蒙特利尔认知评估(MoCA)作为一种简短的认知障碍筛查工具,在脑卒中幸存者中得到了广泛应用。然而,一些研究表明,使用 26 的通用截断值可能不适合在脑卒中环境中检测认知障碍。

目的

我们进行了这项研究,以确定 MoCA 在筛查 PSCI 中的最佳截断值。

方法

检索 PubMed、CINAHL、Embase、Cochrane 图书馆和 Web of Science 以获取合格的研究,截至 2023 年 3 月 23 日。由两名独立研究人员筛选所有研究。使用 Quality Assessment of Diagnostic Accuracy Studies-2 工具评估每个文章的质量。使用双变量混合效应模型汇总敏感性、特异性、阳性似然比、阴性似然比、诊断比值比和综合受试者工作特征曲线。

结果

本综述共纳入了 24 项研究,共计 4231 名患者。尽管没有发表偏倚的证据,但观察到高度的异质性。荟萃分析显示,截断值为 21/22 时具有最佳的诊断准确性。最佳截断值在不同地区、脑卒中类型和脑卒中阶段有所不同。

结论

MoCA 的最佳截断值为 21/22,适用于脑卒中人群,而不是最初推荐的 26。对于脑卒中幸存者,应考虑使用修订后的(较低)截断值。

相似文献

1
Which cutoff value of the Montreal Cognitive Assessment should be used for post-stroke cognitive impairment? A systematic review and meta-analysis on diagnostic test accuracy.用于诊断脑卒中后认知障碍的蒙特利尔认知评估的截断值是多少?一项关于诊断准确性的系统评价和荟萃分析。
Int J Stroke. 2023 Oct;18(8):908-916. doi: 10.1177/17474930231178660.
2
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis.蒙特利尔认知评估在不同阶段和截断值下检测脑卒中后认知障碍的诊断准确性:系统评价和荟萃分析。
Neurol Sci. 2018 Apr;39(4):705-716. doi: 10.1007/s10072-018-3254-0. Epub 2018 Feb 9.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Screening for aspiration risk associated with dysphagia in acute stroke.筛查急性脑卒中吞咽困难相关的吸入风险。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012679. doi: 10.1002/14651858.CD012679.pub2.
7
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings.老年人认知功能减退知情者问卷(IQCODE),用于在各种医疗环境中对痴呆进行早期诊断。
Cochrane Database Syst Rev. 2016 Nov 21;11(11):CD011333. doi: 10.1002/14651858.CD011333.pub2.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
10
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.

引用本文的文献

1
Plasma inflammatory cytokines are associated with cognitive impairment after acute minor ischemic stroke and transient ischemic attack.血浆炎症细胞因子与急性轻度缺血性中风和短暂性脑缺血发作后的认知障碍有关。
Front Immunol. 2025 Aug 1;16:1445938. doi: 10.3389/fimmu.2025.1445938. eCollection 2025.
2
Development of a Diagnostic Prediction Model for Post-Stroke Cognitive Impairment in Acute Large Vessel Occlusion Stroke Using Multimodal MRI and PET/CT: A Study Protocol.使用多模态MRI和PET/CT开发急性大血管闭塞性卒中后认知障碍的诊断预测模型:一项研究方案
Brain Behav. 2025 Jun;15(6):e70613. doi: 10.1002/brb3.70613.
3
Metacognition impairment in stroke.
中风中的元认知障碍
Front Neurol. 2025 Mar 11;16:1501419. doi: 10.3389/fneur.2025.1501419. eCollection 2025.
4
Effects of very early exercise on inflammatory markers and clinical outcomes in patients with ischaemic stroke- a randomized controlled trial.极早期运动对缺血性中风患者炎症标志物及临床结局的影响——一项随机对照试验
BMC Neurol. 2025 Mar 21;25(1):121. doi: 10.1186/s12883-025-04132-5.
5
Association of baseline plasma fibrinogen levels with cognitive and affective status at 30 and 90 days in individuals with ischemic stroke: A prospective study from Nigeria.尼日利亚的一项前瞻性研究:缺血性中风患者基线血浆纤维蛋白原水平与30天和90天时认知及情感状态的关联
Brain Circ. 2024 Dec 28;10(4):308-315. doi: 10.4103/bc.bc_52_24. eCollection 2024 Oct-Dec.
6
Development and internal validation of a nomogram for predicting cognitive impairment after mild ischemic stroke and transient ischemic attack based on cognitive trajectories: a prospective cohort study.基于认知轨迹预测轻度缺血性中风和短暂性脑缺血发作后认知障碍的列线图的开发与内部验证:一项前瞻性队列研究
Front Aging Neurosci. 2025 Jan 29;17:1427737. doi: 10.3389/fnagi.2025.1427737. eCollection 2025.
7
Development and validation of a novel model to predict post-stroke cognitive impairment within 6 months after acute ischemic stroke.一种预测急性缺血性卒中后6个月内发生卒中后认知障碍的新型模型的开发与验证
Front Neurol. 2024 Dec 24;15:1451786. doi: 10.3389/fneur.2024.1451786. eCollection 2024.
8
lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke cognitive impairment.长链非编码RNA six3os1可诊断急性中风,预测疾病严重程度,并预测中风后认知障碍。
BMC Neurol. 2024 Dec 26;24(1):491. doi: 10.1186/s12883-024-04003-5.
9
Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.提高蒙特利尔认知评估对识别中风后认知障碍的诊断准确性。
Sci Rep. 2024 Aug 29;14(1):20125. doi: 10.1038/s41598-024-71184-x.